The Claim
Apigenin directly binds to peroxiredoxin 6 (PRDX6) in senescent cells, inhibiting its phospholipase A2 (iPLA2) activity, which disrupts downstream signaling through HSPA8, ATM, and p38MAPK, thereby suppressing the senescence-associated secretory phenotype (SASP) without inducing cell death.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Apigenin binds to the protein PRDX6 in aging cells, blocks its enzymatic activity, interrupts specific signaling pathways involving HSPA8, ATM, and p38MAPK, and reduces the release of inflammatory molecules associated with cellular aging without killing the cells.
See the scientific wording
Apigenin directly binds to peroxiredoxin 6 (PRDX6) in senescent cells, inhibiting its phospholipase A2 (iPLA2) activity, which disrupts downstream signaling through HSPA8, ATM, and p38MAPK, thereby suppressing the senescence-associated secretory phenotype (SASP) without inducing cell death.
Apigenin attaches to a protein called PRDX6 in old, damaged cells and blocks its ability to release a fatty acid called arachidonic acid. This stops a chain reaction where another protein, HSPA8, normally connects two stress-signaling proteins, ATM and p38MAPK. Without this connection, the cell stops producing inflammatory signals even though it remains old and inactive.
What the research says
1 studyApigenin, a natural compound found in some plants, latches onto a specific protein in old, damaged cells and stops it from sending out inflammatory signals. This reduces the harmful effects of those cells without killing them, which helps improve health in aging mice.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.